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Stable breast cancer cell (BCC) lines are valuable tools for the identification of
breast cancer stem cell (BCSC) phenotypes that develop in response to several
stimuli as well as for studying the basic mechanisms associated with the initia-
tion and maintenance of BCSCs. However, the characteristics of individual, BCC-
derived BCSCs varies and these cells show distinct phenotypes depending on the
different BCSC markers used for their isolation. Aldehyde dehydrogenase (ALDH)
activity is just such a recognized biomarker of BCSCs with a CD44+/CD24 pheno-
type. We isolated BCSCs with high ALDH activity (CD44+/CD24/Aldefluorpos)
from a primary culture of human breast cancer tissue and observed that the cells
had stem cell properties compared to BCSCs with no ALDH activity (CD44+/
CD24/Aldefluorneg). Moreover, we found Aldefluorpos BCSCs had a greater
hypoxic response and subsequent induction of HIF-1a expression compared to
the Aldefluorneg BCSCs. We also found that knocking down HIF-1a, but not HIF-
2a, in Aldefluorpos BCSCs led to a significant reduction of the stem cell properties
through a decrease in the mRNA levels of genes associated with the epithelial-
mesenchymal transition. Indeed, HIF-1a overexpression in Aldefluorneg BCSCs led
to Slug and Snail mRNA increase and the associated repression of E-cadherin and
increase in Vimentin. Of note, prolonged hypoxic stimulation promoted the phe-
notypic changes of Aldefluorneg BCSCs including ALDH activity, tumorigenesis
and metastasis, suggesting that hypoxia in the tumor environment may influence
BCSC fate and breast cancer clinical outcomes.
I t has been reported that CD44 and CD24 are good mark-ers to isolate cancer stem cells (CSC) subpopulations from
breast cancer.(1) CD44+/CD24/low cells are more common
in basal-like tumors and are strongly associated with
BRCA1-mediated hereditary breast cancer but not all
CD44+/CD24/low cells show a basal-like cell phenotype.
Furthermore, not all CD44+/CD24/low populations in breast
tumors are CSCs but rather are non-stem tumor cells, which
have highly proliferative potential and lead to poor clinical
outcomes.(2,3) On the other hand, aldehyde dehydrogenase
(ALDH) was identified as specific marker that can be used
to isolate stem cells from not only normal tissues, but
malignant ones as well.(4) The ALDH phenotype correlated
with clinical outcome; however, no association with a partic-
ular subtype of breast cancer cells (BCCs) was identified.(5)
Ginestier and colleagues found that Aldefluor-positive (for
ALDH activity) BCC populations in mice have a 1% or less
overlap with the population of CD44+/CD24/low cells. Addi-
tionally, Aldefluor-positive and CD44+/CD24/low populations
were reported to have high tumorigenic activity, including
proliferation and tumor formation after transplantation of just
20 cells per recipient mouse.
Because stem cells divide asymmetrically, the cellular pro-
geny exhibits a high degree of differentiation and neoplastic
cells are therefore generally thought to be at various differenti-
ated stages. Importantly, it has been reported that normal and
cancer stem cell-like cells can arise de novo from cells at a
more advanced differentiation stage, indicating that there are
heterogeneous populations regulated by bidirectional intercon-
versions.(6,7) Therefore, non-stem cancer cells give rise to
CSCs due to an unexpected degree of plasticity. However, the
mechanisms of phenotypic changes inducing CSCs have not
been investigated in detail.
One of the key extrinsic effects on cancer cells is a hypoxic
environment. Hypoxia-inducible factor-1a (HIF-1a) is overex-
pressed and is associated with the proliferation of breast, lung,
gastric, skin, ovarian, pancreatic, prostate and renal cancers.(8)
Furthermore, it has been demonstrated that blocking HIF-1a in
breast cancers inhibits tumor growth, angiogenesis, stem cell
maintenance, invasion and metastasis.(9) Increased expression
of HIF-1a is closely related to a poor prognosis and resistance
to therapy in various types of cancers.(10) Hypoxia is also an
important factor in the epithelial-mesenchymal transition
(EMT) in breast cancer.(11) HIF-1a binds to hypoxia response
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elements (HRE) in the Snail and Slug promoters and increases
their expression, while simultaneously decreasing the expres-
sion of E-cadherin, leading to the EMT and increased cancer
aggressiveness.(12,13) These previous findings indicate that
HIF-1a induces cancer development in a variety of aspects,
and it represents a key molecule involved in various cancer-
related processes.
In this study, we isolated breast cancer stem cells (BCSCs)
(CD44+/CD24) with high ALDH activity (Aldefluorpos) from
human breast cancer tissue and showed CD44+/CD24/Aldeflu-
orpos cells had greater stem cell properties and hypoxic response
(as measured by induction of HIF-1a expression) compared to
CD44+/CD24/Aldefluorneg cells. Furthermore, we found HIF-
1a to be highly involved in the generation of Aldefluorpos cells
and induce Snail and Slug expression at both mRNA and protein
levels, leading to the EMT phenotype. Moreover, we identified
hypoxic induction of Aldefluorpos cells from Aldefluorneg cells
and those altered Aldefluorpos cells expressed angiogenic genes
rather than EMT-related genes. Indeed, when hypoxia-induced
Aldefluorpos cells derived from Aldefluorneg stock were trans-
planted into mice, tumorigenic and metastatic activities
increased significantly compared to controls and resembled the
activity Aldefluorpos of cells at time zero.
Materials and Methods
Patient sampling and established cell lines (BC#1). Human
pleural effusion from a metastatic breast cancer patient
(79 years of age, estrogen receptor [ER]-positive, progesterone
receptor [PgR]-positive, human epidermal growth factor recep-
tor 2 [HER2]-negative) was harvested from a surgical sample
using a protocol approved by the ethics committee of the
University of Tsukuba. Isolated cells (ER+/PgR+/HER2) were
plated on tissue culture dishes and expanded in vitro.(14) After
expansion, CD45/CD31/CD44+/CD24 cells (BC#1) were
segregated from the mixed population by FACS (MoFlo XDP;
Beckman Coulter, Brea, CA, USA) and maintained with Dul-
becco’s modified eagle medium (DMEM)-high medium (Invit-
rogen, Carlsbad, CA, USA) containing 10% FBS, L-glutamine
and MEM-NEAA (Invitrogen). We used early passages of
BC#1 (up to passage number 8) for further experiments. We
harvested and cultured four additional breast cancer cell
batches derived from the pleural effusion of different patients,
using the same protocol. One of these batches (BC#1) was
maintained in the same culture condition as above. For control,
MCF-7 (Riken BioResource Center, Ibaraki, Japan) and SK-
BR-3 (ATCC #HTB-30™; Manassas, VA, USA) were utilized.
Antibodies for FACS. The antibodies used in this study were
phycoerythrin (PE)-labeled anti-CD24 (Biolegend, San Diego,
CA, USA), fluorescein isothiocyanate (FITC)-labeled
anti-CD44 (BD Biosciences, San Jose, CA, USA), allophyco-
cyanine (APC)-labeled anti-E-cadherin (Biolegend) and
PE-labeled anti-Vimentin (R&D systems, Minneapolis, MN,
USA).
Aldefluor assay. Aldehyde dehydrogenase activity was ana-
lyzed with Aldefluor reagent (StemCell Technologies Inc, Van-
couver, BC, Canada) according to the manufacturer’s
instructions and a previous report.(15) A single cell suspension
(1 9 106) was mixed with activated ALDH substrate (Stem-
Cell Technologies Inc). Diethylaminobenzaldehyde (DEAB),
which is a specific and irreversible inhibitor of ALDH, was
used as a negative control. Finally, we isolated Aldefluorpos
and Aldefluorneg populations under DEAB-negative conditions
by cell sorter.
Mammosphere formation assay. Sample cells (1 9 104) were
mixed in MammoCult medium (StemCell Technologies Inc)
containing heparin and hydrocortisone and cultured for 7 days.
Mammosphere (diameter ≥100 lm) forming efficiency (MSFE)
was calculated as the number of mammospheres divided by
the original number of cells seeded and indicated as percent-
age.
Cell proliferation assay. Cells (4 9 104) were plated on
35 mm dish and were cultured under normoxic conditions.
Surviving cells were scored at 24-h intervals using the trypan-
blue exclusion method.
Wound healing assay. Cells (1 9 105) were plated on six-
well dishes. After cells reach confluency, a single scratch
wound was created using a p10 micropipette into confluent
cells. The migration distance (lm), at 0 and 24 h after wound-
ing, was calculated using the ImageJ software program.
Matrigel invasion assay. Cells (4 9 104) in DMEM-high con-
taining 0.1% FBS were seeded onto BD Matrigel Basement
Membrane Matrix (BD Biosciences)-coated 8-lm BD Falcon
cell culture insert (BD Biosciences). DMEM containing 10%
FBS was added to the lower compartments of each chamber,
and cells were incubated for 24 h. After removal of the cells
that remain in the top chamber, the top surface of each mem-
brane was cleared of cells with a cotton swab. Cells that had
penetrated to the bottom side of the membrane were then fixed
in methanol, stained with a Diff-Quick Stain Set (Sysmex Cor-
poration, Kobe, Japan), and counted.
Animal studies. Female C57BL/6J mice were purchased from
Japan SLC, Inc (Shizuoka, Japan) and bred under SPF condi-
tions with ad libitum access to food and water. All experimen-
tal procedures were approved by the University of Tsukuba
Institute Animal Care and Use Committee. Sample cells
(2 9 105) were injected into the tail vein and suspensions con-
taining sample cells (5 9 106) in 100 lL of Growth Factor
Reduced BD Matrigel Matrix (BD Biosciences) were injected
into the subcutaneous tissue. After 21 days, the mice were sac-
rificed by cervical dislocation and the primary tumors and
lungs were analyzed. Immunosuppression was performed by
Cyclosporin-A (Sigma-Aldrich, St. Louis, MO, USA) injection
(20 mg/kg per day, i.p.).
Immunohistochemistry. The primary tumors and lungs were
fixed with 4% paraformaldehyde (Wako Pure Chemical,
Osaka, Japan). The sections of tumor samples were stained by
Hematoxylin–Eosin. Four sections per sample were selected at
random and the areas with tumor cell aggregation were mea-
sured. This aggregate area was then divided by the area of
each tumor section to calculate mean tumor burden per tumor
sample. The lung sections were stained by Hematoxylin–Eosin.
Three sections per sample were selected at random and meta-
static foci were counted in each section. Then, the number of
metastases was divided by the area of the each lung section to
calculate mean metastatic density per sample.
Quantitative polymerase chain reaction (qPCR). The cDNA
samples were synthesized from total RNA (2 lg) using a
ReverTra Plus kit (TOYOBO, Osaka, Japan). The reaction
mixtures for quantitative PCR were prepared using THUN-
DERBIRD SYBR qPCR Mix (TOYOBO). The data were cal-
culated by the DDCt method. The sequences of the primers
used for qPCR are shown in Table 1.
Western blotting analysis. Proteins were subjected to Western
blotting as previously described.(16,17) Anti-human HIF-1a
(1:2000; sc-10790, Santa Cruz Biotechnology, Santa Cruz, CA,
USA),(18) anti-human HIF-2a (1:3000; NB100-132, Novus
Biologicals, Littleton, CO, USA),(19) anti-human Snail (1:2000;
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sc-28199, Santa Cruz Biotechnology), anti-human Slug
(1:2000; sc-10436, Santa Cruz Biotechnology), anti-human
Actin (1:2000; sc-1615, Santa Cruz Biotechnology) and anti-
human Lamin B (1:3000; sc-6217, Santa Cruz Biotechnology)
antibodies were used. Then, horse radish peroxidase (HRP)-
conjugated secondary antibodies were incubated according to
the manufacturer’s instructions. The resultant signal was
detected by chemiluminescence using the Immobilon Western
Chemiluminescent HRP substrate (Merck Millipore, Billerica,
MA, USA).
Overexpression and shRNA treatment of HIF-1a and siRNA
treatment of HIF-2a. To overexpress HIF-1a, cells were trans-
fected with pEF-BOS-human HIF-1a or pEF-BOS (control)
using Lipofectamine LTX (Invitrogen). To suppress HIF-1a
expression, we used the MISSION shRNA lentiviral transduc-
tion system (TRCN0000003810; Sigma-Aldrich).(20) GFP-
expressing Aldefluorpos cells were established using MISSION
TurboGFP Control Particle (SHC003V; Sigma-Aldrich) as con-
trol cells. And, to suppress HIF-2a expression, cells were
transfected with either HIF-2a siRNA or negative control
siRNA (Qiagen, Basel, Switzerland), using Lipofectamine
LTX (Invitrogen).(21) All kits were used according to the man-
ufacturer’s instructions.
Chromatin immunoprecipitation (ChIP) assay. Sample cells
(1.5 9 107) were fixed with 1% formaldehyde, then washed
with phosphate-buffered saline (PBS) containing 1 mM pro-
tease inhibitor mixture (Roche Applied Science, Indianapolis,
IN, USA). Nuclear extracts were prepared as described previ-
ously.(22) After fragmentation of DNA by sonication, the sam-
ples were incubated at 4°C with anti-human HIF-1a (1:1000;
NB100-105, Novus Biologicals) or anti-human HIF-2a
(1:1000; NB100-132, Novus Biologicals) antibodies. Normal
rabbit IgG was used as a negative control. The reaction mix-
tures were incubated with protein A-agarose beads (Nacalai
tesque, Kyoto, Japan) and were eluted with elution buffer (1%
SDS, 0.1 M NaHCO3). DNA-protein complexes were dena-
tured at 65°C. The ALDH1A1 HRE sequence was detected by
PCR using Ex Taq polymerase (TAKARA BIO INC, Kyoto,
Japan). The following primers were used: sense primer, 50-
ATCTCACCTTGAATTGTAGTTC-30 and antisense primer,
50-TAATTGACTCACAGTTCAGCAT-30.
Statistical analysis. The data are presented as the
means  SD from three or more independent experiments.
Sample means were compared using Student’s t-test or an
ANOVA, followed by Tukey’s multiple comparison test. Calcula-
tions were executed by the GraphPad Prism software program
(GraphPad Software Inc., La Jolla, CA, USA).
Results
Isolation and characterization of BCSC properties in primary
breast cancer cells. Previous studies have demonstrated that
ALDH activity, reflected by Aldefluorpos status, is a good indi-
cator of breast cancer cell lines that possess stem cell proper-
ties, such as self-renewal activity, tumorigenesis and
metastasis.(5,23) After enrichment for a CD44+/CD24 popula-
tion, we separated BC#1 on the basis of ALDH activity and
cultivated it for further analyses (Fig. 1a).(14) Previously, we
showed that BC#1 is CK5/6+, CK8+, ER+, PgR+, HER2.(14)
In order to validate the phenotype of BC#1 in further detail,
we examined the expression of CK14 (a breast epithelial mar-
ker) and Vimentin (a fibroblast marker), and showed that
BC#1 is CK14+ and Vimentin, suggesting that BC#1 is con-
sisted of breast cancer cells (data not shown). With regard to
cellular morphology, the CD44+/CD24/Aldefluorneg popula-
tion showed an epithelial-like morphology whereas the CD44+/
CD24/Aldefluorpos population showed both epithelial-like and
spindle-shaped morphology (Fig. 1b). The Aldefluorpos cells
proliferated more rapidly compared with the Aldefluorneg cells
as previously reported (Fig. 1c).(23) The mammosphere assay
showed that the Aldefluorpos cells had a higher mean MSFE
than the Aldefluorneg cells in both the primary and secondary
assays (Fig. 1d). And the wound healing assay showed that the
migration distance of the Aldefluorpos cells was greater than
that of the Aldefluorneg cells (Fig. 1e). Furthermore, the matri-
gel invasion assay showed that the number of passed cells per
field of Aldefluorpos cells was more than that of the Aldeflu-
orneg cells (Fig. 1f). These findings fit with previous reports
that deem it likely that the Aldefluorpos cell population may be
enriched in cancer stem/ progenitor cells compared with the
Aldefluorneg cell population.(23,24)
The number of pulmonary metastases was significantly
increased in the mice injected with Aldefluorpos cells compared
with Aldefluorneg cells (Fig. 1g). The Aldefluorpos cell-derived
tumors were larger than those derived from Aldefluorneg cells
and there was a significant difference in the tumor burden
(Fig. 1h). Taken together, these data indicate that Aldefluorpos
BC#1 cells have increased stem cell properties, compared with
Aldefluorneg BC#1 cells, as previously reported.(4,25)
Analysis of the relationship between hypoxia and BCSCs. Pre-
vious reports demonstrated that activated HIFs in BCCs can
promote self-renewal, survival, tumorigenicity, invasiveness
and metastasis.(26–28) Indeed, the HIF-1a expression was sig-
nificantly increased in Aldefluorpos cells compared with Alde-
fluorneg cells under hypoxic conditions (Fig. 2a,b). In contrast,
Table 1. Primers used for Quantitative polymerase chain reaction
(qPCR)
Human HIF-1a Sense: 50-TTACCGAATTGATGGGATATGAG-30
Antisense: 50-TCATGATGAGTTTTGGTCAGATG-30
Human HIF-2a Sense: 50-CTATGTGACTCGGATGGTCTTTC-30
Antisense: 50-ATACCATTTTTGACCCCTCATTT-30
Human
E-cadherin
Sense: 50-CTGGCCTCAGAAGACAGAAGAGAGACT-30
Antisense: 50-CAGCGTGAGAGAAGAGAGTGTATGT
GG-30
Human
Vimentin
Sense: 50-CCGTTGAAGCTGCTAACTACCAAGAC-30
Antisense: 50-GTGGGTATCAACCAGAGGGAGT
GAAT-30
Human Notch-1 Sense: 50-CACTGTGGGCGGGTCC-30
Antisense: 50-GTTGTATTGGTTCGGCACCAT-30
Human Jagged-1 Sense: 50-CTATGATGAGGGGGATGCT-30
Antisense: 50-CGTCCATTCAGGCACTGG-30
Human TGF-b Sense: 50-AGAGCTCCGAGAAGCGGTACCTGAACCC-30
Antisense: 50-GTTGATGTCCACTTGCAGTGTGTTA
TCC-30
Human Snail Sense: 50-AACTACAGCGAGCTGCAGGACTCTAA-30
Antisense: 50-CCTTTCCCACTGTCCTCATCTGACA-30
Human Slug Sense: 50-CTCCTCTTTCCGGATACTCCTCATCT-30
Antisense: 50-CCAGGCTCACATATTCCTTGTCACAG-30
Human
ALDH1A1
Sense: 50-GGAGTGTTGAGCGGGCTAAGAAGTA-30
Antisense: 50-CATTAGAGAACACTGTGGGCTGGAC-30
Human VEGF Sense: 50-AGATGAGCTTCCTACAGCACAAC-30
Antisense: 50-AGGACTTATACCGGGATTTCTTG-30
Human b-actin Sense: 50-GTGCGTGACATTAAGGAGAAGCTGTGC-30
Antisense: 50-GTACTTGCGCTCAGGAGGAGCAATG
AT-30
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HIF-2a was expressed at a similar level under both normoxic
and hypoxic conditions. In addition, there was no significant
difference in the HIF-2a expression between the Aldefluorpos
cells and Aldefluorneg cells (Figs. 2a,b,S1a). We then investi-
gated whether knockdown of HIF-2a expression would affect
the stem cell properties of Aldefluorpos cells and Aldefluorneg
cells. The HIF-2a expression was significantly suppressed in
both cells transfected with HIF-2a siRNA (siHIF-2a) com-
pared with the control (siControl) and HIF-1a expression was
unaffected in the siHIF-2a and the siControl (Fig. 2c,d).
Knockdown of HIF-2a expression in both cell groups led to an
increased dead cell number (Fig. 2e), suggesting that HIF-2a
may have a role in maintaining survival of both Aldefluorpos
and Aldefluorneg cells, as previously reported.(29)
Previous reports demonstrated that HIF-1a triggers the EMT
by decreasing E-cadherin expression and increasing Vimentin
expression.(30,31) The Vimentin mRNA level was increased,
whereas the E-cadherin mRNA level was decreased, in Alde-
fluorpos cells compared with Aldefluorneg cells under hypoxic
conditions (Fig. 2f). Similarly, the FACS analysis showed that
the frequency of E-cadherin-positive cells was markedly
reduced, but the frequency of Vimentin-positive cells was sig-
nificantly elevated in the Aldefluorpos cells (Fig. 2g). We could
detect the change of these EMT markers at the protein level in
the Aldefluorpos cells and considered that the protein levels
reflect cellular milieu more precisely than the mRNA level.
Importantly, previous studies have shown that HIF-1a
activates several signaling pathways, such as the Notch and
TGF-b signaling pathways, which in turn induce the expres-
sion of EMT-associated transcription factors, such as Snail and
Slug.(11,32) We found the expression levels of Notch-1, Jagged-
1 and TGF-b were significantly increased in Aldefluorpos cells
compared with Aldefluorneg cells under hypoxic conditions
(Fig. 2h). In addition, the protein expression of Snail and Slug
were significantly upregulated in Aldefluorpos cells compared
with the Aldefluorneg cells under both normoxic and hypoxic
conditions (Fig. 2i,j). Under normoxic conditions, HIF-1a pro-
tein was slightly increased in Aldefluorpos cells compared with
Fig. 1. The characteristics of Aldefluorneg and Aldefluorpos cells in breast cancer cells (BCCs). (a) The flow cytometric analyses of the ALDH activ-
ity in CD44+/CD24/low cells (BC#1). Isolated Aldefluorpos BC#1 in the solid line and Aldefluorneg BC#1 in the dotted line. (b) The morphology of
Aldefluorneg and Aldefluorpos BC#1. Scale bar = 200 lm. (c) The proliferation of Aldefluorneg (white triangles) and Aldefluorpos (black triangles)
BC#1 under normoxic conditions. (d) The mean mammosphere forming efficiency (MSFE) of the Aldefluorneg and Aldefluorpos BC#1 cultures
determined by the mammosphere formation assay. Primary mammospheres (white bar), secondary mammospheres (black bar). (e) The migration
distance of Aldefluorneg and Aldefluorpos BC#1 was determined by the wound healing assay. (f) The migrated cells per field of Aldefluorneg and
Aldefluorpos BC#1 was determined by the matrigel invasion assay. (g) The number of hematogenous metastases in the lungs of mice that
received Aldefluorneg or Aldefluorpos BC#1 by tail vein injection. (h) Tumor burden size derived from Aldefluorneg or Aldefluorpos BC#1 by subcu-
taneous transplantation. The data are presented as the means  SD from three independent experiments. **P < 0.01 by Student’s t-test or ANOVA
with Tukey’s multiple comparison test.
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Aldefluorneg cells (Fig. 2b). Thus, these data suggested that
HIF-1a might upregulate Snail and Slug expression in Aldeflu-
orpos cells under normoxic conditions as previously
reported.(33–35)
Knockdown of HIF-1a expression in Aldefluorpos cells reduced
their stem cell properties. We then asked whether knockdown
of HIF-1a expression would affect the BCSC properties of
Aldefluorpos cells. The HIF-1a expression was markedly
repressed in Aldefluorpos cells that were transfected with HIF-
1a shRNA (Aldefluorpos-shHIF-1a) compared with the control
(Aldefluorpos-shGFP), whereas there was no significant
difference in the HIF-2a expression in the Aldefluorpos-shHIF-
1a and the control (Figs. 3a,b,S1b). Knocking down HIF-1a
expression in Aldefluorpos cells led to a decreased population
of spindle-shaped cells (data not shown), and knockdown of
HIF-1a in the Aldefluorpos cells affected the number of cells
on day 8, suggesting that HIF-1a knockdown may inhibit the
proliferation of Aldefluorpos cells (Fig. 3c). The mammosphere
formation assay demonstrated that Aldefluorpos-shHIF-1a cells
showed a decreased mean MSFE compared with the control
cells (Fig. 3d). We examined the mRNA expression of stem
regulator genes; OCT4 and Nanog, and found these expression
Fig. 2. Hypoxic response of Aldefluorneg and Aldefluorpos BC#1. (a), (b) The protein expression of hypoxia-inducible factors (HIFs) (HIF-1a and
HIF-2a) in BC#1 cultured under normoxic (20% O2, N: white bar) or hypoxic (1% O2, H: black bar) conditions. (c), (d) The mRNA expression of
HIF-1a and HIF-2a in Aldefluorneg (c) and Aldefluorpos cells (d) transfected with HIF-2a siRNA or Control siRNA under normoxic conditions. (e) The
percentage of dead cells in Aldefluorneg and Aldefluorpos cells after transfection with HIF-2a siRNA under normoxic conditions. (f) The mRNA
expression of E-cadherin and Vimentin in BC#1 cultured under normoxic (white bar) or hypoxic (black bar) conditions. (g) The protein expression
of E-cadherin and Vimentin in BC#1 cultured under normoxic (white bar) or hypoxic (black bar) conditions for 24 h, as determined by flow
cytometry. (h) The mRNA expression of each factor in BC#1 cultured under normoxic (white bar) or hypoxic (black bar) conditions. (i), (j) The pro-
tein expression of Snail and Slug in BC#1 cultured under normoxic (20% O2, N: white bar) or hypoxic (1% O2, H: black bar) conditions as deter-
mined by Western blotting analysis. The data are presented as the means  SD from three independent experiments. *P < 0.05; **P < 0.01 by
Student’s t-test or ANOVA with Tukey’s multiple comparison test.
© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd
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levels were significantly decreased, suggesting that knockdown
of HIF-1a suppresses the maintenance of stemness of Aldeflu-
orpos cells (data not shown). Furthermore, the wound healing
assay demonstrated that the migration distance of Aldefluorpos-
shHIF-1a cells was smaller than that of the control cells
(Fig. 3e). And the matrigel invasion assay showed that Alde-
fluorpos-shHIF-1a cells showed reduced number of invasive
cells per field compared with the control cells (Fig. 3f).
We then examined the number of pulmonary metastases, and
found that the number of foci was significantly decreased by
the injection of Aldefluorpos-shHIF-1a cells compared with the
control (Fig. 3g). An in vivo subcutaneous transplantation
assay also demonstrated that tumors derived from Aldefluorpos-
shHIF-1a cells showed a decreased weight and volume
compared with the control (data not shown). The histological
analyses of tumor sections by Hematoxylin–Eosin staining
Fig. 3. Reduction of stem cell properties in Aldefluorpos BC#1 by hypoxia-inducible factor (HIF)-1a knockdown. (a), (b) The protein expression of
HIF-1a and HIF-2a in Aldefluorpos-shGFP or Aldefluorpos-shHIF-1a BC#1 cells cultured under normoxic (N: white bar) or hypoxic (H: black bar) con-
ditions. (c) The cell proliferation activities of Aldefluorpos-shGFP (white triangles) and Aldefluorpos-shHIF-1a (black triangles) cells under normoxic
conditions. (d) The mean mammosphere forming efficiency (MSFE) for the first mammospheres (white bar) and secondary mammospheres (black
bar). (e) The migration activities. (f) The cell invasion activities. (g) The number of hematogenous metastases in the lungs. (h) The size of tumor
burden derived from Aldefluorpos-shHIF-1a cells. (i) The mRNA expression of E-cadherin and Vimentin in cells cultured under normoxic (white
bar) or hypoxic (black bar) conditions. (j) The protein expression of E-cadherin and Vimentin in cells cultured under normoxic (white bar) or
hypoxic (black bar) conditions for 24 h, was determined by flow cytometry. (k) The mRNA expression of each factor in cells cultured under nor-
moxic (white bar) or hypoxic (black bar) conditions. The data are presented as the means  SD from three independent experiments. *P < 0.05;
**P < 0.01 by Student’s t-test or ANOVA with Tukey’s multiple comparison test.
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clearly showed a decreased tumor burden in the mice bearing
Aldefluorpos-shHIF-1a cells compared with the control
(Fig. 3h).
In order to determine whether knockdown of HIF-1a
affected the expression of EMT-related genes, we examined
the E-cadherin and Vimentin expression in Aldefluorpos-shHIF-
1a cells. Increased expression of E-cadherin and decreased
expression of Vimentin was observed in the HIF-1a knock-
down Aldefluorpos cells under hypoxic conditions (Fig. 3i).
Similarly, the FACS analysis showed that the frequency of E-
cadherin-positive cells was markedly increased, but the fre-
quency of Vimentin-positive cells was significantly decreased
in the HIF-1a knockdown Aldefluorpos cells (Fig. 3j). Further-
more, we found a significant decrease in the expression of
Notch-1, Jagged-1, TGF-b, Snail and Slug in the Aldefluorpos-
shHIF-1a cells compared with control cells under hypoxic
conditions (Fig. 3k). In addition, we examined whether Notch
signaling blocks Hypoxia-induced EMT in Aldefluorpos cells
using a Notch inhibitor (DAPT), and showed the expression of
EMT-related genes, in Aldefluorpos cells treated with DAPT,
were significantly increased under the hypoxic conditions
(Fig. S2). However, the expression level of the EMT-related
genes; Snail and Slug in Aldefluorpos cells treated with DAPT
was lower compared with the control cells. These results indi-
cated that a Notch inhibitor could not block total hypoxia-
induced EMT, suggesting Notch signaling-induced EMT is
partially but not fully dependent on hypoxia. Collectively,
these results suggest that HIF-1a is highly associated with the
stem cell properties of Aldefluorpos cells by promoting the
EMT process.
HIF-1a overexpression induced the elevated expression of Snail
and Slug mRNA in Aldefluorneg cells. We then transfected HIF-
1a into Aldefluorneg cells to determine whether HIF-1a overex-
pression induces Snail or Slug in BCCs. The HIF-1a protein
was constitutively expressed even under normoxic conditions
in the HIF-1a-transfected Aldefluorneg cells (Fig. 4a,b). The
Aldefluorneg-pEF-BOS-HIF-1a cells showed epithelial mor-
phology and seemed to contain more spindle-shaped cells than
the control (Aldefluorneg-pEF-BOS cells) (data not shown). We
also found decreased expression of E-cadherin and increased
expression of Vimentin in the Aldefluorneg-pEF-BOS-HIF-1a
cells compared with the control (Fig. 4c). Similarly, the FACS
analysis showed that the frequency of E-cadherin-positive cells
was markedly decreased, but the frequency of Vimentin-
positive cells was significantly increased in the Aldefluorneg-
pEF-BOS-HIF-1a cells (Fig. 4d). There were no significant
differences in Notch-1, Jagged-1 or TGF-b expression whereas
the expression levels of Snail and Slug were significantly
increased in the Aldefluorneg-pEF-BOS-HIF-1a cells (Fig. 4e).
These results indicate that HIF-1a overexpression was
involved in triggering the EMT process, which occurred
through the repression of E-cadherin due to the induction of
Snail and Slug expression in the Aldefluorneg cells.
The number of pulmonary metastases was markedly
increased in mice injected with Aldefluorneg-pEF-BOS-HIF-1a
cells compared with the control (Fig. 4f). The tumor burden of
the mice injected with Aldefluorneg-pEF-BOS-HIF-1a cells was
significantly higher than the control (Fig. 4g). Taken together,
these results indicate that HIF-1a affects the phenotypic
change of BCSC population in regards to tumorigenesis and
metastasis.
Aldefluorneg cells were altered to Aldefluorpos cells in a process
directly regulated by HIF-1a. It has been reported that the
mRNA level of ALDH1A1 positively correlates with the
ALDH activity in BCSCs.(36) The expression of ALDH1A1
was significantly increased in the Aldefluorneg-pEF-BOS-HIF-
1a cells and the expression of ALDH1A1 was significantly
decreased in the Aldefluorpos-shHIF-1a cells (Fig. 5a). Indeed,
the ALDH activity in the Aldefluorpos-shHIF-1a cells was
markedly decreased compared with the control Aldefluorpos
Fig. 4. The stem cell properties of Aldefluorneg BC#1 cells were increased by hypoxia-inducible factor (HIF)-1a-overexpression. (a), (b) The pro-
tein expression of HIFs (HIF-1a and HIF-2a) in Aldefluorneg-pEF-BOS (pEF-BOS) and Aldefluorneg-pEF-BOS-HIF-1a (pEF-BOS-HIF-1a) BC#1 was exam-
ined in cells cultured under normoxic conditions. (c) The mRNA expression of E-cadherin and Vimentin in cells cultured under normoxic
conditions. (d) The protein expression of E-cadherin and Vimentin in cells cultured under normoxic conditions. (e) The mRNA expression of each
factor in cells cultured under normoxic conditions. (f) The number of hematogenous metastases in the lungs. (g) Tumor burden size derived from
pEF-BOS-HIF-1a BC#1. The data are presented as the means  SD from three independent experiments. *P < 0.05; **P < 0.01 by Student’s t-test.
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cells. On the other hand, the ALDH activity in the Aldeflu-
orneg-pEF-BOS-HIF-1a cells was markedly increased compared
with the control Aldefluorneg-pEF-BOS cells (Fig. 5b). These
results indicate that HIF-1a expression is highly associated
with the increase in ALDH activity via a direct and/or indirect
manner.
In order to address specificity in HIF-1a or HIF-2a binding
to the ALDH1A1 promoter, we performed a ChIP assay using
Aldefluorpos and Aldefluorneg cells. A direct association of
HIF-1a with the ALDH1A1 promoter was observed in Aldeflu-
orpos cells under normoxic and hypoxic conditions, whereas
HIF-1a bound to the ALDH1A1 promoter in Aldefluorneg cells
under hypoxic conditions (Fig. 5c). On the other hand, HIF-2a
could not bind to the ALDH1A1 promoter in both Aldefluorpos
and Aldefluorneg cells.
Remarkably, we found that exposure to hypoxic stimuli for
over 72 h significantly increased the frequency of Aldefluorpos
cells in the Aldefluorneg population and led to a slight increase
in total Aldefluorpos cells (Fig. 5d), suggesting that the ALDH
activity in BC#1 may be regulated by HIF-1a in some part. In
fact, the phenotypic change from Aldefluorneg cells to Aldeflu-
orpos cells was observed after 72 h under hypoxic conditions.
We could detect similar phenomena using other breast cancer
cell lines; MCF7 (HER2-negative) and SK-BR-3 (HER2-posi-
tive), suggesting that the alteration of Aldefluorpos cells derived
from Aldefluorneg cells might not be HER2-negative specific
(Fig. S3). In addition, we found that those altered Aldefluorpos
cells derived from Aldefluorneg cells had increased expression
of angiogenesis-related mRNA rather than EMT master genes
(Fig. 5e).
Furthermore, the number of pulmonary metastases was sig-
nificantly increased when hypoxia-induced Aldefluorpos cells
derived from Aldefluorneg populations were injected and the
number of metastatic foci caused by those population reached
a similar level as native Aldefluorpos cells (Fig. 5f). In addi-
tion, the tumor burden of the mice injected with these derived
cells was significantly higher than those of the mice injected
with Aldefluorneg cells and was similar in level to Aldefluorpos
cells (Fig. 5g).
Next we examined how ALDH1A1 contributes to the alter-
ation process from Aldefluorpos to Aldefluorneg cells under
hypoxic conditions. We treated Aldefluorpos cells with an
ALDH1A1 inhibitor. It was clearly shown that an ALDH1A1
inhibitor suppress the increase of Aldefluorpos cells derived
from Aldefluorneg cells under hypoxic conditions, suggesting
that ALDH expression is associated with the alteration of
Aldefluorpos cells from Aldefluorneg cells (data not shown).
Taken together, these results suggest that under hypoxic con-
ditions, generation of Aldefluorpos cells might be induced by a
different mechanism and those phenotypically altered Aldeflu-
orpos populations might be highly associated with angiogenesis
in tumor development (Fig. 5h).
Discussion
Previous studies have suggested that traditional cancer treat-
ments are effective for cancer reduction but fail to eliminate
the CSCs that result in metastasis and recurrence. In order to
examine the characteristics of BCSCs, we isolated primary cul-
tured human breast cancer cells, BC#1, from a pleural effusion
of breast cancer and selected CD44+/CD24 cells from which
Aldefluorpos or Aldefluorneg populations were derived. The
CD44+/CD24/Aldefluorpos cells possessed more BCSC prop-
erties than the CD44+/CD24/Aldefluorneg cells. Charafe-
Jauffret et al.(5) found that 23 out of 33 breast cancer cell lines
examined contained an Aldefluor-positive population that dis-
played stem cell properties in vivo as well as in in vitro assays.
These results suggested that high ALDH activity is a useful
stem cell marker for primary cells as established BCC
lines.(4,37)
In the case of tumorigenesis several HIF target genes play
critical roles.(38) Among these HIF targeting genes, angiogenic
factors, such as vascular endothelial growth factor (VEGF), are
well-known target genes that play important roles in cancer
development. Of critical importance is the previous report that
HIF-1a protein was not detected in specimens from normal
breast tissue or ductal hyperplasia but was detected in the
majority of samples of ductal carcinoma in situ and invasive
cancer specimens.(27) Recently, several anti-angiogenic drugs
have been developed; however, a previous study demonstrated
that treatment with anti-angiogenic agents, including sunitinib
and bevacizumab, actually increased the population of BCSCs
and promoted tumorigenesis through HIF-1a activation.(36) In
this study, we showed that HIF-1a, rather than HIF-2a, is the
key molecule associated with the maintenance of the stem cell
properties of BCSCs. In addition, we found that HIF-1a
expression, but not HIF-2a expression, was markedly increased
in Aldefluorpos cells compared with Aldefluorneg cells in pri-
mary culture of BCCs and that HIF-2a is associated with the
survival of both Aldefluorpos and Aldefluorneg cells in the cul-
ture. Collectively, it is suggested that HIF-1a expression is an
important phenotype maintenance factor for BCSCs and that
HIF-2a is important for cellular survival.(3)
Hypoxic stimuli also exert physiological effects that can
induce the EMT in tumors through multiple distinct mecha-
nisms, including the upregulation of HIF-1a, or activation of
the Notch or NF-jB pathways.(33,39) Recent studies have
demonstrated that HIF-1a-mediated EMT is linked to CSC
characteristics in brain cancer.(40) In the present study, we
found that the both mRNA and protein levels of EMT trigger
genes, Snail and Slug, were markedly increased in Aldefluorpos
cells compared with Aldefluorneg cells in primary cultured
BCCs. Indeed, knockdown of HIF-1a expression in the Alde-
fluorpos cells reduced their capacity for self-renewal and their
proliferation potential in vitro, as well as their tumorigenesis
and metastasis in vivo, through inhibiting the EMT process via
decreases in expression levels of Snail and Slug. We also
found that HIF-1a overexpression in Aldefluorneg cells
increased the expression of Snail and Slug, thereby repressing
the expression of E-cadherin and inducing the expression of
Vimentin.
Importantly, we found that HIF-1a directly induced
ALDH1A1 mRNA expression, resulting in the production of
Aldefluorpos cells derived from Aldefluorneg population by
HIF-1a. Ginestier and colleagues proposed that ALDH1
expression in a subset of tumors may reflect the transformation
of ALDH-positive stem or early progenitors. By contrast,
ALDH1-negative tumors may be generated by the transforma-
tion of ALDH1-negative progenitor cells.(4) In this study, we
could identify the generation of Aldefluorpos cells from some
part of the Aldefluorneg population under direct regulation by
HIF-1a. This result suggests that a small subset of the stem
cell population would possess the reverse ability in terms of
the expression of ALDH1A1. If this hypothesis is correct, it
will be important to investigate the mechanism by which the
ALDH expression is switched among CSCs and progenitor
populations. Further analyses would be necessary to clarify this
possible mechanism.
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Interestingly, Gupta and colleagues showed BCSC-like cells
arise de novo from non-stem-like cells and explained the cell
transition state by a Markov model.(6) According to this model,
they revealed that interconversion between stem-like fractions
and non-stem like fractions (luminal and basal cells) occurs
after transplantation in vivo.(7) In the present study, because
Aldefluorneg cells partially possess characteristics of BCSCs, it
is likely that the magnitude of phenotypic change in CSCs,
such as ALDH activity, would be controlled by microenviron-
mental factors (e.g., hypoxia) and subsequent effects on the
epigenetic state of the Aldefluorneg population.
In conclusion, hypoxia found in breast cancer tumors is one
the most important processes responsible for the induction of
HIF-1a in BCSCs. Consistent with previous reports, it is
suggested that a combination of chemotherapy and HIF-1a
inhibitor would be more effective compared with the current
therapy.(41) We also predict that inhibition of HIF-1a that can
inhibit ALDH activity in highly hypoxic breast cancer tumor
microenvironments will reduce the chances to generate delete-
rious Aldefluorpos BCSCs.
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